Biogen Inc.

NASDAQ Global Select
Back to all articles
Slightly Bullish +15

Stocks making the biggest moves premarket: Biogen, Vertiv, GE HealthCare, Generac & more

📈 Biogen shares gained 0.7% after beating revenue and earnings estimates and raising full-year adjusted EPS guidance.

📉 Vertiv stock tumbled 13% despite an earnings beat because organic revenue growth of 17.8% missed the 23.6% consensus forecast.

⚡ Generac jumped 5.5% on better-than-expected second-quarter earnings of $2.91 per share, beating the $2.01 forecast and reiterating revenue guidance.

📉 Procter & Gamble shares dropped over 3% after quarterly revenue of $21.2 billion missed the $21.38 billion analyst expectation.

🏥 GE HealthCare Technologies rose 12% following second-quarter adjusted EPS of $1.13, which beat the $1.04 consensus and reaffirmed full-year guidance.

📈 Deutsche Bank rose more than 2% on record after-tax profits of 1.9 billion euros for the second quarter.

✈️ General Dynamics shares increased nearly 1% after beating revenue and earnings estimates with a backlog of $136.5 billion.

🚗 Ford Motor surged 6% after posting adjusted earnings that beat expectations and hiking its 2026 earnings outlook.

📉 CoStar stock fell 15% after second-quarter revenue failed to meet the $967.5 million consensus forecast.

🧥 Rocky Brands surged 16% as second-quarter earnings per share more than tripled from a year ago aided by tariff refunds.

🎨 PPG Industries dropped around 1% after adjusted EPS and EBITDA missed Wall Street estimates despite reaffirming full-year guidance.

🔬 KLA Corp slid 7% after issuing disappointing guidance with first-quarter earnings expected at $1.16 versus a $1.14 estimate.

💾 Seagate Technology rose 6% on an outlook that trounced analyst expectations with first-quarter earnings projected at $7.30 per share.

📦 Manhattan Associates climbed 11% after second-quarter earnings and revenue topped estimates and raised full-year forecasts.

💳 Visa lost 2% after guidance for the 2026 fiscal year underwhelmed the Street, accompanied by a plan to cut 2,600 jobs.

Bullish Signals
  • Biogen beat Wall Street consensus estimates on revenue and earnings and raised its full-year adjusted EPS guidance.
  • Generac reported second-quarter earnings of $2.91 per share, significantly beating the FactSet forecast of $2.01 per share.
  • GE HealthCare Technologies reported second-quarter adjusted EPS of $1.13, beating the FactSet consensus of $1.04 per share.
  • Deutsche Bank posted an after-tax profit of 1.9 billion euros, a record for the period.
  • General Dynamics beat Wall Street consensus estimates on revenue and earnings per share with a backlog of $136.5 billion.
  • Ford Motor posted second-quarter adjusted earnings that beat expectations and hiked its 2026 earnings outlook.
  • Rocky Brands reported second-quarter earnings per share that more than tripled from the same period a year ago.
  • Seagate issued an outlook for first-quarter adjusted earnings of around $7.30 per share, trouncing analysts' expectations of $5.80.
  • Manhattan Associates topped analyst estimates for second-quarter earnings and revenue and raised full-year profit and revenue forecasts.
  • Teradyne's second-quarter adjusted earnings, revenue, and third-quarter profit and sales forecasts all topped Street estimates.
Risk Factors
  • Vertiv's revenue year-on-year organic growth of 17.8% was well below the FactSet consensus of 23.6%, causing shares to tumble 13%.
  • Procter & Gamble's quarterly revenue of $21.2 billion missed analyst expectations, leading to a drop of over 3% in shares.
  • CoStar's second-quarter revenue failed to meet the expectation of analysts surveyed by FactSet, resulting in a 15% stock decline.
  • PPG Industries' second-quarter earnings per share and adjusted EBITDA missed Wall Street analysts' estimates.
  • KLA Corp issued disappointing guidance with first-quarter adjusted earnings expected at $1.16 versus the LSEG estimate of $1.14.
  • Visa's guidance for the 2026 fiscal year underwhelmed the Street, causing shares to lose 2% and prompting a plan to slash about 2,600 jobs.
Full Analysis
Biogen (BIIB) shares rose 0.7% in premarket trading after the biotechnology company reported second-quarter results that beat Wall Street consensus estimates for both revenue and earnings. The positive market reaction was further amplified by the company's decision to raise its full-year adjusted earnings per share guidance, signaling stronger-than-expected financial performance and confidence in future prospects. Vertiv (VRT) experienced a significant decline of 13% despite reporting mixed results where earnings and revenue beat analyst expectations. The stock tumbled primarily because the company's year-over-year organic revenue growth of 17.8% fell well below the FactSet consensus forecast of 23.6%, highlighting a divergence between absolute performance and growth rate expectations in the AI infrastructure sector. This premarket roundup covers a broad range of market movers including Generac, GE HealthCare, and Procter & Gamble, alongside major technology and industrial names like KLA Corp, Seagate, and Visa. The article details specific stock price movements driven by earnings beats, misses, guidance revisions, and strategic announcements such as job cuts at Visa or tariff refunds aiding Rocky Brands.